Generalised anxiety disorder (and some potential co-morbid symptoms/conditions) Mental and Behavioural Disorders Generalized anxiety disorder
Conditions
Interventions
Participants will be randomly allocated to one of two active parallel interventions: an experimental intervention (Emotion-Focused Therapy for GAD
EFT for GAD), and a well-established benchmark comparison (Cognitive Behavioural Therapy
CBT for GAD). Participants will be randomly assigned to either EFT or CBT intervention with a 1:1 allocation, nested within therapists, as per a computer generated randomisation schedule (online rando
Sponsors
HSE Counselling in Primary Care
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Participants will be recruited from medical card holding, adult (18 years and older) clients, referred by their GP to the HSE Counselling in Primary Care (CIPC) service (a service offered by the Irish public health service provider) 2. Participants must meet criteria for a primary diagnosis of Generalised Anxiety Disorder on the Structured Clinical Interview for DSM-V 3. Participants must agree to be part of the study and consent to study conditions (including giving consent for sessions to be recorded and agreeing to attend appointments for follow up assessments) 4. Clients on medication will be allowed to enter the study provided that their medication has been stabilised for at least 6 weeks
Exclusion criteria
Exclusion criteria: 1. Concurrent treatment 2. Suicide risk, or risk of harm to others (as indicated by items on the CORE-OM) 3. Substance abuse 4. Psychosis 5. Organic brain syndrome
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of Generalised Anxiety Disorder symptoms, assessed using the GAD-7 questionnaire (Spitzer, Kroenke, Williams and Löwe, 2006) at pre-treatment, post-treatment, and at 6 month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) The Clinical Outcome in Routine Evaluation – Outcome Measure (CORE-OM; Evans et al., 2000); (2) The Generalised Anxiety Disorder Severity Scale (GADSS; Shear, Belnap, Mazumdar, Houck and Rollman, 2006); and (3) The Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001). (4) In addition, a subset of items (e.g. questions 10 - 17) from the Counselling in Primary Care (CIPC) Client Satisfaction Survey, which is routinely administered to all CIPC clients at end of therapy, will be analysed. 1. Psychological distress across four domains (subjective well-being, problems or symptoms, life functioning and risk), measured using the Clinical Outcome in Routine Evaluation – Outcome Measure (CORE-OM; Evans et al., 2000) at pre-treatment, post-treatment, and at 6 month follow-up 2. GAD specific symptom severity, measured using the Generalised Anxiety Disorder Severity Scale (GADSS; Shear, Belnap, Mazumdar, Houck and Rollman, 2006) at pre-treatment, post-treatment, and at 6 month follow-up 3. Severity of depression symptoms, assessed using the Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer, & Williams, 2001) at pre-treatment, post-treatment, and at 6 month follow-up 4. Client satisfaction with various aspects of therapy and service delivery, measured using a subset of items (e.g. questions 10 - 17) from the Counselling in Primary Care (CIPC) Client Satisfaction Survey at end of therapy | — |
Countries
Ireland
Outcome results
None listed